Patents by Inventor Lutz Deitinghoff

Lutz Deitinghoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7771952
    Abstract: This invention relates to drug screening using mammalian repulsive guidance molecules and mammalian Neogenin. In addition, the invention provides for methods of preventing, alleviating or treating various disorders of the nervous system, angiogenic disorders or disorders of the cardio-vascular system and malignancies of different etiology by disrupting the interaction between RGM and Neogenin.
    Type: Grant
    Filed: June 26, 2003
    Date of Patent: August 10, 2010
    Assignee: Abott Laboratories
    Inventors: Stephen Strittmatter, Bernhard Mueller, Lutz Deitinghoff
  • Publication number: 20060252101
    Abstract: This invention relates to drug screening using mammalian repulsive guidance molecules and mammalian Neogenin. In addition, the invention provides for methods of preventing, alleviating or treating various disorders of the nervous system, angiogenic disorders or disorders of the cardio-vascular system and malignancies of different etiology by disrupting the interaction between RGM and Neogenin.
    Type: Application
    Filed: June 26, 2003
    Publication date: November 9, 2006
    Inventors: Stephen Strittmatter, Bernhard Mueller, Lutz Deitinghoff